Shilpa Medicare gets EU GMP status for Finished Dosage Formulation Facility in Telangana

02 Apr 2020 Evaluate

Shilpa Medicare has received EU GMP status for its Finished Dosage Formulation Facility (Sterile and Non-sterile) located at Pharmaceutical Formulations SEZ, TSIIC, Jadcherla, Telangana State, India from Austrian Authority (AGES) for the inspection held during January 13, 2020 to January 17, 2020.

The company’s affiliates have registered their products (Oral solids & Injections) with European authorities for commercial distribution. The renewed EU GMP facilitates continued supply of products to European Union.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

315.85 -4.50 (-1.40%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 901.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×